San Clemente, California-based Reflow designed the new microcatheters for complex coronary interventions. They introduce enhancements focused on spinning freedom and torque transmission. The company said this supports controlled navigation and lesion crossing in challenging anatomies.
Reflow’s new catheters incorporate refinements to hub design, shaft construction and distal profile. The updates aim to improve handling, pushability and trackability.
Cora Flex supports navigation in tortuous vessels, septals and microchannels. Reflow said Cora Force features a metal tip, adding further pushability and tip force in more resistant, calcified and fibrotic lesions.
The company built the microcatheters on its Cora Tech, a proprietary construction with a no-liner design with PTFE-coated coils. This design enables unrestricted torque rotation. Meanwhile, the systems’ stainless-steel brain aims to support controlled torque transmission and catheter stability. In addition to spinning freedom, predictable torque transmission offers precise control, especially when navigating tortuous vessels.
“From an engineering perspective, we focused on optimizing rotational behavior, torque transmission, and overall handling characteristics,” said Outhit Bouasaysy, VP of engineering at Reflow Medical. “These enhancements reflect direct physician input and our targeted approach to building endovascular solutions to advance the treatment of challenging coronary lesions.”
Cora Flex and Cora Force join the company’s expanding portfolio of vascular devices. That includes the Spur peripheral stent and the Spur sirolimus-eluting scaffold.
“The U.S. launch of the next-generation Cora platform represents an important step in expanding our coronary portfolio to support patients with coronary artery disease,” said Dejan Ilic, VP, global marketing at Reflow Medical.
